Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | PTPRZ1 | P23471 | 1/20 | 0.47 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 3/20 | 0.46 |
| ▸ | CA2 | P00918 | 3/20 | 0.46 |
| ▸ | CA5A | P35218 | 2/20 | 0.46 |
| ▸ | CA9 | Q16790 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA3 | P07451 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
| ▸ | CA6 | P23280 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL776228 | 0.85 | HTR6 (0.46) | HTR6SMN1; SMN2LMNAMAPK1HTT | |
| SCHEMBL5664875 | 0.82 | HTR6 (0.48) | HTR6SMN1; SMN2ALDH1A1APOBEC3GCA1 | |
| SCHEMBL8519013 | 0.82 | ALDH1A1 (0.57) | SMN1; SMN2LMNAMAPK1HTTALDH1A1 | |
| SCHEMBL13088070 | 0.81 | LMNA (0.43) | HTR6SMN1; SMN2LMNAMAPK1HTT | |
| SCHEMBL8941634 | 0.81 | HTT (0.57) | HTR6SMN1; SMN2LMNAMAPK1HTT | |
| SCHEMBL775525 | 0.80 | HTR6 (0.46) | HTR6SMN1; SMN2ALDH1A1APOBEC3GCA1 | |
| SCHEMBL2853702 | 0.80 | HTR6 (0.46) | HTR6SMN1; SMN2ALDH1A1APOBEC3GCA1 | |
| SCHEMBL6053237 | 0.80 | HSD11B1 (0.47) | HTR6SMN1; SMN2ALDH1A1APOBEC3GCA1 | |
| SCHEMBL18986850 | 0.80 | ALDH1A1 (0.48) | HTR6SMN1; SMN2LMNAHTTALDH1A1 | |
| SCHEMBL6709353 | 0.78 | HSD11B1 (0.40) | ALDH1A1APOBEC3GTSHRKIF11HSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 336 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115417787-A | Extractant for rapidly and efficiently separating and extracting strontium and preparation method thereof | 四川大学 | 2022-12-02 | — | — | CN | claimed |
| CN-114899487-A | Electrolyte with phenyl trifluoromethanesulfone as additive and lithium ion battery thereof | 湖南大学 | 2022-08-12 | — | — | CN | claimed |
| WO-2022093716-A1 | SYMMETRICAL OR ASYMMETRICAL ALKYLSULFONYL IMIDE OR CYCLIC ALKYLENE SULFONYLIMIDE SALTS AS CATHODE ADDITIVES, ELECTROLYTE ADDITIVES, OR SI ANODE ADDITIVES FOR SI ANODE-BASED LI-ION CELLS | ENEVATE CORPORATION (US) | 2022-05-05 | — | — | WO | claimed |
| US-20220131193-A1 | SYMMETRICAL OR ASYMMETRICAL ALKYLSULFONYL IMIDE OR CYCLIC ALKYLENE SULFONYLIMIDE SALTS AS CATHODE ADDITIVES, ELECTROLYTE ADDITIVES, OR SI ANODE ADDITIVES FOR SI ANODE-BASED LI-ION CELLS | ENEVATE CORPORATION | 2022-04-28 | — | — | US | claimed |
| CN-112538005-B | Preparation method of 1,3, 5-trimethoxybenzene | 南京艾德凯腾生物医药有限责任公司 | 2022-04-12 | — | — | CN | claimed |
| CN-109420525-B | Metal iridium catalyst of 2, 2' -bis-benzimidazole ligand and method for synthesizing N-methylated primary amine by using metal iridium catalyst | 南京理工大学 | 2021-10-08 | — | — | CN | claimed |
| CN-112538005-A | Preparation method of 1,3, 5-trimethoxybenzene | 南京艾德凯腾生物医药有限责任公司 | 2021-03-23 | — | — | CN | claimed |
| CN-108026610-B | Method for separating americium from liquid radioactive substances and separating americium from rare earth elements | 俄罗斯国家原子能公司 | 2020-05-12 | — | — | CN | claimed |
| EP-3296411-B1 | METHOD FOR ISOLATING AMERICIUM FROM LIQUID RADIOACTIVE WASTE AND FOR SEPARATING AMERICIUM FROM RARE EARTH ELEMENTS | STATE ATOMIC ENERGY CORP ROSATOM BEHALF RUSSIAN FEDERATION (RU) | 2020-03-18 | — | — | EP | claimed |
| US-10590513-B2 | Method for isolating americium from liquid radioactive waste and for separating americium from rare earth elements | STATE ATOMIC ENERGY CORPORATION “ROSATOM” ON BEHALF OF THE RUSSIAN FEDERATION (RU) | 2020-03-17 | — | — | US | claimed |
| WO-2000045635-A1 | THIAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF | LION BIOSCIENCE AG (DE) | 2000-08-10 | — | — | WO | claimed |
| WO-2000025768-A1 | OXADIAZOLE, THIADIAZOLE AND TRIAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF | TREGA BIOSCIENCES, INC. (US) | 2000-05-11 | — | — | WO | claimed |
| US-5672760-A | OBTAINING A PHOTOABSORBER-CONTAINING ACRYLIC POLYMER BY USING N-2-HYDROXYETHYL-N-ETHYL ANILINE TO OBTAIN 4-((2-HYDROXYETHYL)ETHYLAMINO)-4'-(TRIFLUOROMETHYLSULFONYL)-TOLANE WHICH REACTS WITH A POLYMERIZABLE METHACRYLIC ACID | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 1997-09-30 | — | — | US | claimed |
| US-4771062-A | ENZYME INHIBITORS | BAYER AKTIENGESELLSCHAFT (DE) | 1988-09-13 | — | — | US | claimed |
| EP-0240680-A1 | Diaryl sulfide derivatives | BAYER AG (DE) | 1987-10-14 | — | — | EP | claimed |
| US-4659720-A | POULTRY ANTIPROTOZOA AGENT | MERCK & CO., INC. (US) | 1987-04-21 | — | — | US | claimed |
| EP-0113570-B1 | 5-(AMINO OR SUBSTITUTED AMINO) IMIDAZOLES | MERCK & CO. INC. (US) | 1987-02-25 | — | — | EP | claimed |
| US-4622330-A | Antiprotozoal 3-amino or substituted amino pyrazoles | MERCK & CO., INC. (US) | 1986-11-11 | — | — | US | claimed |
| EP-0113570-A1 | 5-(Amino or substituted amino) imidazoles | MERCK & CO. INC. (US) | 1984-07-18 | — | — | EP | claimed |
| US-3941453-A | Birefringent compounds used in Kerr cells | U.S. PHILIPS CORPORATION (US) | 1976-03-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220131193-A1 | SYMMETRICAL OR ASYMMETRICAL ALKYLSULFONYL IMIDE OR CYCLIC ALKYLENE SULFONYLIMIDE SALTS AS CATHODE ADDITIVES, ELECTROLYTE ADDITIVES, OR SI ANODE ADDITIVES FOR SI ANODE-BASED LI-ION CELLS | HCN2, IDH2, KCNJ1 | HTR6 4628/4885SMN1; SMN2 637/4885LMNA 1751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.